Jennifer Crombie, MD - Dana-Farber ...

Dr. Jennifer Crombie, MD

Claim this profile

Dana-Farber Cancer Institute

Studies Lymphoma
Studies B-Cell Lymphoma
5 reported clinical trials
11 drugs studied

Area of expertise

1Lymphoma
Jennifer Crombie, MD has run 5 trials for Lymphoma. Some of their research focus areas include:
MYC positive
BCL-2 positive
BCL-6 positive
2B-Cell Lymphoma
Jennifer Crombie, MD has run 3 trials for B-Cell Lymphoma. Some of their research focus areas include:
MYC positive
BCL-2 positive
BCL-6 positive

Affiliated Hospitals

Image of trial facility.
Dana Farber Cancer Institute
Image of trial facility.
Brigham And Women's Hospital

Clinical Trials Jennifer Crombie, MD is currently running

Image of trial facility.

Pembro + CAR T-Cell Therapy

for Large B-Cell Lymphoma

This research study is evaluating the combination of drugs, pembrolizumab with chimeric antigen receptor (CAR) T-cell therapy, as a possible treatment for primary mediastinal B-cell lymphoma that has recurred after prior treatment. The names of the study drugs involved in this study are: - Pembrolizumab Standard treatment will include: * CAR T-cell therapy (either axicabtagene-ciloleucel or lisocabtagene maraleucel) * Cyclophosphamide * Fludarabine
Recruiting1 award Phase 2

More about Jennifer Crombie, MD

Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Jennifer Crombie, MD has experience with
  • Copanlisib
  • Venetoclax
  • Obinutuzumab
  • Rituximab
  • Glofitamab
  • Polatuzumab
Breakdown of trials Jennifer Crombie, MD has run
Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Lymphoid Leukemia
Non-Hodgkin's Lymphoma

Other Doctors you might be interested in

Sapna Syngal, MDDana Farber Cancer Center, Harvard University
Gregory Cote, MDMassachusetts General Hospital
James M. ClearyDana Farber Cancer Institute

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jennifer Crombie, MD specialize in?
Jennifer Crombie, MD focuses on Lymphoma and B-Cell Lymphoma. In particular, much of their work with Lymphoma has involved MYC positive patients, or patients who are BCL-2 positive.
Is Jennifer Crombie, MD currently recruiting for clinical trials?
Yes, Jennifer Crombie, MD is currently recruiting for 1 clinical trial in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Jennifer Crombie, MD has studied deeply?
Yes, Jennifer Crombie, MD has studied treatments such as Copanlisib, Venetoclax, Obinutuzumab.
What is the best way to schedule an appointment with Jennifer Crombie, MD?
Apply for one of the trials that Jennifer Crombie, MD is conducting.
What is the office address of Jennifer Crombie, MD?
The office of Jennifer Crombie, MD is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security